Table 1.
Patient characteristics
| Number | 229 |
| Age | 62.7 ± 11.8(18–87) |
| Sex (male/female) | 134 (58.5%)/95 (41.5%) |
| Body mass index (kg/m2) | 21.1 ± 9.4 (14.5–53.5) |
| Etiology(HCV/HBV/HBV+HCV/alcohol/NASH/PBC/AIH/PBC+AIH/PSC/NBNC) | 71 (31%)/14 (6.1%)/1 (0.4%)/50 (21.9%)/31 (13.5%)/20 (8.7%)/7 (3.1%)/2 (0.9%)/3 (1.3%)/30 (13.1%) |
| Esophageal varices, n (%) | |
| None | 75 (32.8%) |
| Small | 53 (23.1%) |
| Medium | 71 (31%) |
| Large | 30 (13.1%) |
| Gastric fundal varices (None/small/medium/large) | 158 (69%)/22 (9.6%)/31 (13.5%)/18 (7.9%) |
| Portal hypertensive gastropathy (−/+) | 171 (74.7%)/58 (25.3%) |
| Ascites (−/mild/moderate to severe) | 149 (65.1%)/57 (24.9%)/23 (10%) |
| Splenomegaly (−/+) | 68 (29.7%)/161 (70.3%) |
| Hepatocellular carcinoma | 175 (76.4%)/54 (23.6%) |
| Blood test | |
| Platelet count (×109/L) | 89.6 ± 49(77–300) |
| Aspartate aminotransferase (IU/L) | 53.1 ± 44(3–420) |
| Alanine aminotransferase (IU/L) | 34.9 ± 37.8(2–501) |
| Albumin (g/dL) | 3.3 ± 0.7 (1.0–4.7) |
| Total bilirubin (mg/dL) | 2.0 ± 2.6 (0.1–22.6) |
| Prothrombin time (%) | 75.5 ± 20.6 (5–125) |
| Plt/Spla | 767.1 ± 530.2 (44.2–3180) |
| Child-Pugh score | 7.2 ± 2.0 (5–14) |
| Child-Pugh classification (A/B/C)b | 98 (42.8%)/98 (42.8%)/28 (12.2%) |
Data are expressed as number or mean ± standard deviation (percentage or range)
AIH autoimmune hepatitis, HBV hepatitis B virus, HCV hepatitis C virus, HBV hepatitis B virus, NASH non-alcoholic steatohepatitis, NBNC non B non C, PBC primary biliary cholangitis, Plt/Splplatelet count/spleen diameter ratio, PSC primary sclerosing cholangitis
a Calculated by the formula, platelet count/spleen bipolar diameter
b Five patients were excluded because of taking warfarin